Startup CorriXR spun out from ChristianaCare research
WILMINGTON - ChristianaCare has spun out its first commercial biotech company focused on gene-editing technology to develop new cancer treatments. CorriXR Therapeutics launched Tue…
WILMINGTON - ChristianaCare has spun out its first commercial biotech company focused on gene-editing technology to develop new cancer treatments. CorriXR Therapeutics launched Tue…